The peptide remains available through "research peptide" suppliers who sell it labeled as "not for human consumption." This legal gray area allows it to be purchased without a prescription, compounding the safety concern: the purity, sterility, and actual contents of these products are not guaranteed by any regulatory body
The evidence for split dosing with retatrutide specifically is limited since clinical trials used once-weekly dosing exclusively
Research suggests it may influence angiogenesis (formation of new blood vessels), cellular repair signaling, and tissue healing pathways
Plus, right now, New York Post readers can save 12% off their first order with code NYPOST12
and has served as a board director for George Clinical, St Vincents Health Australia, and several independent medical research institutes